Press Releases and Statements

CHPA’s President and CEO, Scott Melville, released a statement in response to the introduction of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

CHPA has issued a statement in response to a recent, observational NSAID study published in the journal Science Translational Medicine.

The Consumer Healthcare Products Association (CHPA) today announced the hiring of Logan Tucker as Director of Communications and Media Relations.

CHPA President and CEO Scott Melville released a statement in response to Senator Durbin’s and Senator Braun’s Introduction of the Dietary Supplement Listing Act of 2022.

CHPA President and CEO Scott Melville released a statement today following the recent passing of former U.S. Senator Orrin Hatch.

The Consumer Healthcare Products Association applauds the confirmation of Judge Ketanji Brown Jackson to the United States Supreme Court.

The Consumer Healthcare Products Association issued a statement from President and CEO Scott Melville regarding the Food and Drug Administration’s (FDA) fiscal year 2023 budget request.

New data-driven tool will help CHPA educate stakeholders on the role of dietary supplements in healthcare.

At its annual Self-Care Leadership Summit (SLS) this week, CHPA welcomed 20 new members since last year – five manufacturers and 15 associate members – reflecting the broadening landscape in personal healthcare including OTC medicines, dietary supplements, and consumer medical devices. Additionally, the association and CHPA Educational Foundation elected several new board members and officers.

The Consumer Healthcare Products Association (CHPA) awarded its Ivan D. Combe Lifetime Achievement Award to longtime industry leader Gary Downing at the opening session of the organization’s annual Self-Care Leadership Summit (SLS).

The Consumer Healthcare Products Association (CHPA) applauds the recent appointment of Cara Welch, Ph.D., as Director of the FDA Office of Dietary Supplement Programs (ODSP).